Search results for: COVID-19 Research
Filter search results
Dr. Cheong Wei Yang
8 March 2024
As Vice Provost (Strategic Research Partnerships) at SMU, Dr Cheong develops multi-disciplinary, strategic research partnerships with government and industry, to advance the international standing of SMU’s research in areas of…
Realising the Value of Medical Research: Health and Economic Benefits
20 March 2013
…in research and development and speeding up the NHS’s currently slow rate rate of uptake of the results of research. Economic and Health Benefits of Research from Office of Health…
Recently Published: Payer Perspectives on Future Acceptability of Comparative Effectiveness and Relative Effectiveness Research
18 August 2015
…Towse, A., 2015. Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020. Journal of Comparative Effectiveness Research (Epub ahead of print). Download the full paper…
Crisis in Research
1 April 1986
…spending on housing or consumer expenditure on tobacco (1983 data). This present paper examines the state of research in Britain today. The analysis is first concerned with scientific research in…
Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations
1 December 2021
…Manchester and Cancer Research UK Research Paper. Available here. See here for the supplementary report. Related Research Cole, A., Cubi-Molla, P., Pollard, J., Sim, D., Sullivan, R., Sussex, J. and…
Medical Research: What’s It Worth?
1 November 2008
…the cost of that research. The report includes time series estimates of public/charitable and private pharmaceutical industry expenditure on medical research; explores the concept of knowledge ‘spillovers’ from public and…
How Much Should Society Pay for a New Orphan Drug? A Contribution to this Debate is now Available in a New OHE Research Paper
18 July 2018
…Research shows that, on average, the estimated research and development (R&D) cost of an orphan drug is around the 27% of the cost of a non-orphan. However, potential market revenue…
OHE Innovation Policy Prize
18 May 2022
…delivers for each and every one of us. The record-breaking development of multiple COVID-19 vaccines, potential curative gene therapies for spinal muscular atrophy, or even the antibiotics which enables medicine…
Estimating the Impact of U.S. Drug Price-setting Policies on Innovation Is Challenging, Even for the Congressional Budget Office
22 June 2022
…has the potential to significantly reduce the rate of biopharmaceutical innovation – which has played a pivotal role in the development of novel vaccines and treatments during the COVID-19 pandemic…